Study identifier:NIS-NKR-SER-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Effectiveness of atypical antipsychotics on anhedonic features in patients with schizophrenia
schizophrenia
-
No
-
All
231
Observational
20 Years +
Allocation: - 
Endpoint Classification: - 
Intervention Model: - 
Masking: - 
Primary Purpose: - 
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
| Arms | Assigned Interventions | 
|---|